Trendlines Group announced that the Office of the Chief Scientist of the Israel Ministry of Economy (OCS) has approved Trendlines Medical’s request to establish 9 to 11 new portfolio companies a year in medical device and agtech fields.
At the same time, OCS has also approved the group’s request to expand the mandate of its subsidiary Trendlines Medical-Misgav’s OCS incubator licence to include agtech investments.
New agtech investments will be made under the Trendlines Medical incubator said the group. The group can tap on OCS financial support for new agtech investments on top of its own US$10 million Bayer Trendlines Ag Innovation Fund, which invests in early-stage agricultural technologies.
The OCS licence ends in 2023.
Trendlines ended 4.4% higher at 19 cents on Monday.
Click Here To Register For Free Trial Services OR Give A Missed Call : +6531581402 Follow Us On Twitter : www.twitter.com/epicresearchsg Like Us On Facebook : www.facebook.com/EpicResearchSingapore Need Any Assistance Feel Free To Mail Us at : info@epicresearch.sg
At the same time, OCS has also approved the group’s request to expand the mandate of its subsidiary Trendlines Medical-Misgav’s OCS incubator licence to include agtech investments.
New agtech investments will be made under the Trendlines Medical incubator said the group. The group can tap on OCS financial support for new agtech investments on top of its own US$10 million Bayer Trendlines Ag Innovation Fund, which invests in early-stage agricultural technologies.
The OCS licence ends in 2023.
Trendlines ended 4.4% higher at 19 cents on Monday.
Click Here To Register For Free Trial Services OR Give A Missed Call : +6531581402 Follow Us On Twitter : www.twitter.com/epicresearchsg Like Us On Facebook : www.facebook.com/EpicResearchSingapore Need Any Assistance Feel Free To Mail Us at : info@epicresearch.sg
0 comments:
Post a Comment